PI PERSPECTIVE May 1995 Now Available from Project Inform

The new issue of PI PERSPECTIVE, a newsletter published three
times a year, is now available.

It includes articles on:

* Research: "Last year has brought more advances in the
treatment of AIDS than perhaps any similar period in the
history of the epidemic" -- but complacency and lack of
leadership have prevented their optimal use.

* New antivirals: Major results of studies of d4T, and of
3TC.

* Immune-based therapies: In-depth report on Project Inform's
Immune Restoration Think Tank.

* Protease inhibitors: Merck MK-639; Abbott ABT-538;
Hoffmann-La Roche saquinavir; and Agouron AG1343.

* CMV treatment advances: Ocular implants; HPMPC; combining
ganciclovir and foscarnet.

* Prophylaxis: Developments in preventing pneumocystis,
fungal infections, MAC, CMV, and toxoplasmosis.

* Kaposi's sarcoma: Controversies in interpretation of data
on the important new drug DOX-SL, which is not yet approved
but recommended for approval by an FDA advisory committee.

* Pediatric AIDS: Advances and issues in the prevention and
treatment of AIDS in infants and children.

* How to interpret results of the quantitative PCR or
branched DNA tests for HIV RNA copy number.

* The Project Inform "Basic Message": Seven points on dealing
with HIV infection.

To obtain a copy of PI PERSPECTIVE and a basic treatment
information packet call the Project Inform hotline, 800/822-
7422, or 415/558-9051, Monday through Saturday 10-4 Pacific
Time.